PATH | VRL
Menu

Find resources

Total results with these characteristics: 1845

Page 92 of 93
WHO Policy Development Processes for a New Vaccine: Case Study of Malaria Vaccines

This article, published in Malaria Journal, analyzed the World Health Organization policy development process to predict its course for a malaria vaccine. Data needs for a malaria vaccine include safety; the demonstration of efficacy in a range of …

Author: Milstien J, Cardenas V, Cheyne J, Brooks A

Publication date: 2010

WHO Policy Statement: Multi-dose Vial Policy (MDVP) - Handling of Multi-dose Vaccine Vials After Opening

This document is designed to provide guidance to national and senior-level program managers on the proper handling of multi-dose vaccine vials once opened. It presents the World Health Organization’s official position on this issue, including the …

Author: World Health Organization

Publication date: 2014

WHO Preferred Product Characteristics for Group B Streptococcus Vaccines

This report provides guidance on vaccine development strategies and targets for group B Streptococcus vaccines. It includes key clinical research and development considerations as well as preferred product characteristics such as indication, target …

Author: World Health Organization

Publication date: 2017

WHO Preferred Product Characteristics for Respiratory Syncytial Virus (RSV) Vaccines

This report provides guidance on vaccine development strategies and targets for RSV vaccines. It includes key clinical research and development considerations as well as preferred product characteristics such as indication, target population, …

Author: World Health Organization

Publication date: 2017

WHO Preferred Product Characteristics (PPC) for Malaria Vaccines

This document provides guidance for vaccine manufacturers and funding agencies in refining their product development plans for malaria vaccines. It clarifies the World Health Organization's preferences with regard to many criteria that form part of …

Author: World Health Organization

Publication date: 2014

WHO Prequalified Vaccines

This web page provides a database of vaccines prequalified by the World Health Organization which allows the user to search by manufacturer, vaccine, or country of manufacture. The database is tailored to support immunization program managers, …

Author: World Health Organization

WHO Recommendations for Routine Immunization: Summary Tables

These summary tables are designed to assist program managers in developing optimal immunization schedules using key information from the World Health Organization (WHO). The first table summarizes recommended routine immunizations for all age …

Author: World Health Organization

Publication date: 2017

WHO Recommendations Regarding Vaccine Hesitancy

Vaccine hesitancy refers to delay in acceptance or refusal of safe vaccines despite availability of vaccination services. This special issue of Vaccine is guest-edited by the World Health Organization (WHO) and focuses on the topic of vaccine …

Author: Schuster M, Duclos P, eds.

Publication date: 2015

WHO Vaccine Reaction Rates Information Sheets

This web page provides links to information sheets on reaction rates of selected vaccines. The papers are primarily designed for use by national public health officials and immunization program managers. Data from these sheets can be used for the …

Author: World Health Organization

WHO/Health Canada Drafting Group Meeting on Scientific and Regulatory Considerations on the Stability Evaluation of Vaccines Under Controlled Temperature Chain

On December 4 to 6, 2012, a consultation was held under the auspices of the World Health Organization (WHO) and Health Canada in Ottawa to identify obstacles to further developing a controlled temperature chain for vaccines. As described in this …

Author: World Health Organization

Publication date: 2013

Whom and Where Are We Not Vaccinating? Coverage After the Introduction of a New Conjugate Vaccine Against Group A Meningococcus in Niger in 2010

The authors of this article, published in PLoS ONE, evaluated the first two phases of the introduction campaign of a new conjugate vaccine, MenAfriVac™, in Niger. They determined which sub-populations or areas …

Author: Kim SH, Pezzoli L, Yacouba H, et al.

Publication date: 2012

WHO's Key Normative Processes and Institutions for Vaccines: A Primer

This policy brief describes three World Health Organization (WHO) normative institutions and processes pertaining to the issuance of technical guidelines and opinons about the public health value of new vaccines, their quality, and the …

Author: International AIDS Vaccine Institute

Publication date: 2008

Why Invest in Communication for Immunization? Evidence and Lessons Learned

This report identifies communication challenges that affect the success of immunization services; offers evidence of the contributions of communication activities; identifies lessons learned, and suggests ways in which communication can continue to …

Author: Waisbord S and Larson H

Publication date: 2005

Will the Decade of Vaccines Mean Business as Usual?

The authors of this article, published in The Lancet, argue that anticipated advances in vaccinology during this new Decade of Vaccines (named by the Bill & Melinda Gates Foundation in January 2010) will only translate into reductions in …

Author: Rees H, Madhi SA

Publication date: 2011

Working to Beat Malaria: The Malaria Vaccine Implementation Programme

This video discusses the development of the RTS,S malaria vaccine, its pilot introduction in selected areas of three African countries as part of the World Health Organization-coordinated Malaria Vaccine Implementation Programme, and why this is a …

Author: PATH

Publication date: 2018

Workshop on Vaccine Pressure and Neisseria Meningitidis, Annecy, France, 9-11 March 2005

This article, published in the journal Vaccine, summarizes a 2005 three-day workshop held in Annecy, France, that reviewed the current state of knowledge regarding Neisseria meningitidis capsule switching and vaccine pressure from capsular …

Author: Alonso JM, Gilmet G, Rouzic EM, et al.

Publication date: 2007

The World Bank: Health

The World Bank’s global strategy for health, nutrition, and population centers on strengthening health systems, including systems for the delivery of life-saving vaccines. This web page provides information about their health projects around the …

Author: The World Bank

World Health Organization Definition of "Radiologically Confirmed Pneumonia" May Under-estimate the True Public Health Value of Conjugate Pneumococcal Vaccines

The public health benefit of conjugate pneumococcal vaccine (PCV) in preventing pneumonia would only be appreciated if the tool used for measuring “pneumococcal pneumonia” had good sensitivity. Exploratory studies in South Africa …

Author: Madhi S, Klugman K

Publication date: 2007

World Health Organization Podcast, Episode 45: A New Meningitis Vaccine is Being Introduced to Prevent Epidemics in Sub-Saharan Africa

This podcast discusses the introduction of a new vaccine to prevent epidemics of meningitis in sub-Saharan Africa. The podcast features Dr. Eric Bertherat, from the World Health Organization (WHO) department of Epidemic Pandemic Alert and …

Author: World Health Organization

Publication date: 2008

World Immunization Week

To underscore the importance of immunization in saving lives and to encourage families to vaccinate their children against deadly diseases, the World Health Organization (WHO) aims to unite countries across the globe for a week each year through …

Author: World Health Organization

Page 92 of 93